Finley Baba, MPH
Project Director
Finley Baba (she/her) is a Project Director involved in ANSIRH’s body of work around expanding access to medication abortion. She works on research focusing on alternative and emerging models of medication abortion provision including telehealth care, pharmacy dispensing, and examining the feasibility of over-the-counter (OTC) access. She has expertise in research management, survey design, and quantitative methods. Finley has been at ANSIRH since 2016 and has helped lead ANSIRH’s diversity, equity, inclusion, and accessibility (DEIA) efforts. She studied Public Health and Latin American Studies at Tulane University and received her MPH from Tulane.
Citations
- Baba F, Ralph LJ, Biggs MA, McNicholas C, Miller AH, Grossman D. Satisfaction with and Feasibility of No-Test Telehealth Medication Abortion vs In-Person Care with Ultrasound in the United States. Contraception. April 2026; https://doi.org/10.1016/j.contraception.2026.111459.
- Ralph LJ, Baba F, Ehrenreich K, Natalie Morris, MPH, Biggs MA, Blanchard K, Hernández E, Kapp N, Kromenaker T, Perritt J, Raymond EG, Kari White, Grossman D. Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label. JAMA Internal Medicine. April 2026; https://doi.org/10.1001/jamainternmed.2026.0298.
- Biggs MA, Baba F, Ralph LJ, Schroeder R, McNicholas C, Miller AH, Grossman D. Psychosocial burden when accessing medication abortion when using no-test telehealth care compared to in-person care with ultrasound. Contraception. March 2025; https://doi.org/10.1016/j.contraception.2025.110894.
- Ralph LJ, Baba F, Biggs MA, McNicholas C, Miller AH, Grossman D. Comparison of No-Test Telehealth and In-Person Medication Abortion. JAMA. June 2024; https://doi.org/10.1001/jama.2024.10680.
- Natalie Morris, MPH, Biggs MA, Baba F, Seymour JW, Kari White, Grossman D. Interest in and Support for Alternative Models of Medication Abortion Provision Among Patients Seeking Abortion in the United States. Women's Health Issues. April 2024; https://doi.org/10.1016/j.whi.2024.03.003.
- Suárez-Baquero D, Dzuba LG, Romero M, Baba F, Biggs MA. Failure of the Law to Grant Access to Legal Abortion in Chile. Health Equity. March 2024; https://doi.org/10.1089/heq.2023.0.
- Ehrenreich K, Baba F, Raifman S, Grossman D. Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States. Women's Health Issues. April 2023; https://doi.org/10.1016/j.whi.2023.03.007.
- Kaller S, Ma M, Gurazada T, Baba F, Rafie S, Raine-Bennett T, Averbach S, Chen M, Berry E, Meckstroth KR, Grossman D. "No Big Deal”: A Qualitative Study of Pharmacists’ Perspectives on Dispensing Mifepristone for Medication Abortion. Women's Health Issues. July 2022; DOI: 10.1016/j.whi.2022.06.007.
- Kaller S, Natalie Morris, MPH, Biggs MA, Baba F, Rafie S, Raine-Bennett T, Creinin MD, Berry E, Micks EA, Meckstroth KR, Averbach S, Grossman D. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion. Journal of the American Pharmacists Association. June 2021; S1544-3191(21)00285-5. [Epub ahead of print].
- Grossman D, Baba F, Kaller S, Biggs MA, Raifman S, Gurazada T, Rafie S, Averbach S, Meckstroth KR, Micks EA, Berry E, Raine-Bennett T, Creinin MD. Medication abortion with pharmacist dispensing of mifepristone. Obstetrics & Gynecology. March 2021; [Epub ahead of print].
- Casas L, Freedman LR, Ramm A, Correa S, Baba F, Biggs MA. Chilean medical and midwifery faculty's views on conscientious objection for abortion services. International Perspectives on Sexual and Reproductive Health. December 2020; 46(1):25-34.
The latest research
See allApril 10, 2026
Satisfaction with and Feasibility of No-Test Telehealth Medication Abortion vs In-Person Care with Ultrasound in the United States
Baba F, Ralph LJ, Biggs MA, McNicholas C, Miller AH, Grossman D. Satisfaction with and Feasibility of No-Test Telehealth Medication Abortion vs In-Person Care with Ultrasound in the United States. Contraception. April 2026; https://doi.org/10.1016/j.contraception.2026.111459.
April 6, 2026
Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label
Ralph LJ, Baba F, Ehrenreich K, Natalie Morris, MPH, Biggs MA, Blanchard K, Hernández E, Kapp N, Kromenaker T, Perritt J, Raymond EG, Kari White, Grossman D. Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label. JAMA Internal Medicine. April 2026; https://doi.org/10.1001/jamainternmed.2026.0298.
March 27, 2025
Psychosocial burden when accessing medication abortion when using no-test telehealth care compared to in-person care with ultrasound
Biggs MA, Baba F, Ralph LJ, Schroeder R, McNicholas C, Miller AH, Grossman D. Psychosocial burden when accessing medication abortion when using no-test telehealth care compared to in-person care with ultrasound. Contraception. March 2025; https://doi.org/10.1016/j.contraception.2025.110894.
June 24, 2024
Comparison of No-Test Telehealth and In-Person Medication Abortion
Ralph LJ, Baba F, Biggs MA, McNicholas C, Miller AH, Grossman D. Comparison of No-Test Telehealth and In-Person Medication Abortion. JAMA. June 2024; https://doi.org/10.1001/jama.2024.10680.
April 23, 2024
Interest in and Support for Alternative Models of Medication Abortion Provision Among Patients Seeking Abortion in the United States
Natalie Morris, MPH, Biggs MA, Baba F, Seymour JW, Kari White, Grossman D. Interest in and Support for Alternative Models of Medication Abortion Provision Among Patients Seeking Abortion in the United States. Women's Health Issues. April 2024; https://doi.org/10.1016/j.whi.2024.03.003.